Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review-Reference-Cited by-同舟云学术

Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review

Published:2021-06 Issue: Volume:35 Page:100444
ISSN:1755-4365
Container-title:Epidemics
language:en
Short-container-title:Epidemics

Author:

Mezei Alex^ORCID,Cohen Jamie,Renwick Matthew J.^ORCID,Atwell Jessica,Portnoy Allison^ORCID

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Microbiology,Parasitology,Epidemiology

Reference47 articles.

1. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model;Acedo;Math. Comput. Model.,2010

2. Transmission patterns and evolution of respiratory syncytial virus in a community outbreak identified by genomic analysis;Agoti;Virus Evol.,2017

3. Vaccination against respiratory syncytial virus in pregnancy;Atwell;Lancet Infect. Dis.,2016

4. Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea;Atwell;J. Infect. Dis.,2015

5. Epidemic dynamics of respiratory syncytial virus in current and future climates;Baker;Nat. Commun.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential impact of nirsevimab and bivalent maternal vaccine against RSV bronchiolitis in infants: A population-based modelling study;Journal of Infection and Public Health;2024-08

2. Fractional Optimal Control Model and Bifurcation Analysis of Human Syncytial Respiratory Virus Transmission Dynamics;Fractal and Fractional;2024-01-11

3. Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study;Vaccine: X;2023-12

4. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies;Vaccine;2023-11

5. Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia;Beneficial Microbes;2023-05-01